Clinical Trial Update: A Single Centre Study in Healthy Volunteers to Optimise the Rotacap Formulation and ROTAHALER Device for Delivery of Fluticasone Propionate/Salmeterol [Phase 1]

View source ↗

Summary

A Phase 1, single-centre study in healthy volunteers completed by GlaxoSmithKline to optimise the Rotacap formulation and ROTAHALER device for delivering Flutic…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma

Drugs mentioned

• Fluticasone propionate/salmeterol (fluticasone propionate/salmeterol)

Snippet

Sponsor: GlaxoSmithKline | Conditions: Asthma | Phase 1 | Status: COMPLETED